DUPONT PHARMACEUTICALS

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Income

$460K

Filings

Unique Clients

Active Period

1999–2000

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2000	$260,000	3	1
1999	$200,000	1	1

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
DUPONT PHARMACEUTICALS	$460,000	4	1999–2000

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	4
SENATE	4

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	4

Source: Senate LDA

DUPONT PHARMACEUTICALS — Lobbying Disclosure | Poliscope